News
Portfolio Press Release

Sept. 18, 2020

Pipeline Therapeutics Appoints Lori Lyons-Williams to its Board of Directors

​Read more

Sept. 10, 2020

Totient Partners with Ginkgo Bioworks to Apply Unique Discovery Platform to COVID-19 Antibody Efforts

​Read more

Sept. 10, 2020

Totient Comes Out of Stealth with Novel COVID-19 Program and $10M in Seed Funding for AI-Driven Drug Discovery Platform

​Read more

July 28, 2020

Pipeline Therapeutics to Present at 3 Upcoming Investor Conferences

​Read more

July 23, 2020

Pipeline Therapeutics Initiates Phase 1/2a Clinical Trial of PIPE-505 in Sensorineural Hearing Loss

Read more

July 17, 2020

X-Vax Technology Appoints Issac Blech as Vice Chairman to its Board of Directors

Read more

July 14, 2020

Landos Biopharma Announces First Human Dosing in a Phase 1 Study of NX-13, its novel candidate for Inflammatory Bowel Disease

​Read more

Dec 2019

Pipeline Therapeutics Completes $30 Million Series B Financing

Read more

Nov 2019

Landos to Present at the 31st Annual Piper Jaffray Healthcare Conference

Read more

Sept 2019

Tangible Science, VSP Optics introduce Unity BioSync Contact Lenses

Read more

Aug 2019

Landos launches two phase II trials

Read more

Aug 2019

Landos Biopharma Completes $60 Million Series B

Read more

Jul 2019

X-Vax Technology Raises $56 Million in Upsized Series A

Read more

May 2019

Landos Biopharma Announces Publication of Results from First-in-Human Phase 1 Study of BT-11 in Healthy Volunteers

Read more

©2019 by Helicase Venture. All rights reserved